Pioneering Phage Therapy
Developing solutions for multidrug-resistant bacterial infections
Phage Therapy: The Next Generation of Medicine
With the rapid rise of multidrug-resistant (MDR) bacteria, traditional antibiotics are becoming less effective. Phage therapy offers a groundbreaking alternative by using naturally occurring viruses (bacteriophages) to selectively target and destroy harmful bacteria without disrupting beneficial microbes.
A Leader in Phage Innovation
Over 3200 phage strains in our library
Focused on ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.)
Advanced phage engineering and synthetic biology techniques.
Global Impact & Collaborations
We partner with leading research institutions, universities, and hospitals to advance clinical applications of phage therapy. With active laboratories in both the UK and Turkey, we are committed to developing cutting-edge solutions and conducting groundbreaking research.
About UsFuture of Phage-Based Medicine
Pushing the boundaries of synthetic biology, genetic engineering, and AI-driven phage selection to develop next-generation therapeutics. Our work is paving the way for a post-antibiotic era where bacterial infections are no longer a major global threat.
